Cargando…
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
High-dose regimes containing etoposide, carboplatin and an oxazaphospharine can salvage 30–40% of patients with relapsed or refractory male germ cell tumours (GCTs). The additional benefit of paclitaxel in such high-dose therapy has not been tested. Between March 1995 and November 2002, 36 male GCT...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410221/ https://www.ncbi.nlm.nih.gov/pubmed/15026797 http://dx.doi.org/10.1038/sj.bjc.6601664 |